Literature DB >> 15971409

Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.

Peter J Havel1.   

Abstract

Fructose intake and the prevalence of obesity have both increased over the past two to three decades. Compared with glucose, the hepatic metabolism of fructose favors lipogenesis, which may contribute to hyperlipidemia and obesity. Fructose does not increase insulin and leptin or suppress ghrelin, which suggests an endocrine mechanism by which it induces a positive energy balance. This review examines the available data on the effects of dietary fructose on energy homeostasis and lipid/carbohydrate metabolism. Recent publications, studies in human subjects, and areas in which additional research is needed are emphasized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971409     DOI: 10.1301/nr.2005.may.133-157

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  196 in total

1.  Fructose acutely stimulates NKCC2 activity in rat thick ascending limbs by increasing surface NKCC2 expression.

Authors:  Gustavo R Ares; Kamal M Kassem; Pablo A Ortiz
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-05

2.  Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.

Authors:  Alfonso Galderisi; Cosimo Giannini; Michelle Van Name; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

3.  Consumption of added sugars is decreasing in the United States.

Authors:  Jean A Welsh; Andrea J Sharma; Lisa Grellinger; Miriam B Vos
Journal:  Am J Clin Nutr       Date:  2011-07-13       Impact factor: 7.045

Review 4.  Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?

Authors:  Mark S Segal; Elizabeth Gollub; Richard J Johnson
Journal:  Eur J Nutr       Date:  2007-09-01       Impact factor: 5.614

5.  Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.

Authors:  Miguel A Lanaspa; Laura G Sanchez-Lozada; Yea-Jin Choi; Christina Cicerchi; Mehmet Kanbay; Carlos A Roncal-Jimenez; Takuji Ishimoto; Nanxing Li; George Marek; Murat Duranay; George Schreiner; Bernardo Rodriguez-Iturbe; Takahiko Nakagawa; Duk-Hee Kang; Yuri Y Sautin; Richard J Johnson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  Effects of long-term consumption of a high-fructose diet on conventional cardiovascular risk factors in Sprague-Dawley rats.

Authors:  Mohammad M Abdullah; Natalie N Riediger; Qilin Chen; Zhaohui Zhao; Nazila Azordegan; Zuyuan Xu; Gabor Fischer; Rgia A Othman; Grant N Pierce; Paramjit S Tappia; Jitao Zou; Mohammed H Moghadasian
Journal:  Mol Cell Biochem       Date:  2009-02-24       Impact factor: 3.396

Review 7.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

Review 8.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

9.  Dietary fructose inhibits intestinal calcium absorption and induces vitamin D insufficiency in CKD.

Authors:  Veronique Douard; Abbas Asgerally; Yves Sabbagh; Shozo Sugiura; Sue A Shapses; Donatella Casirola; Ronaldo P Ferraris
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

10.  Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women.

Authors:  Michael M Swarbrick; Kimber L Stanhope; Sharon S Elliott; James L Graham; Ronald M Krauss; Mark P Christiansen; Steven C Griffen; Nancy L Keim; Peter J Havel
Journal:  Br J Nutr       Date:  2008-11       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.